274 related articles for article (PubMed ID: 31495404)
1. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
Gordhan BG; Peters J; Kana BD
Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
[TBL] [Abstract][Full Text] [Related]
2. Dormancy models for Mycobacterium tuberculosis: A minireview.
Alnimr AM
Braz J Microbiol; 2015; 46(3):641-7. PubMed ID: 26413043
[TBL] [Abstract][Full Text] [Related]
3. Fighting tuberculosis by drugs targeting nonreplicating
Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism.
Lai RPJ; Cortes T; Marais S; Rockwood N; Burke ML; Garza-Garcia A; Horswell S; Sesay AK; O'Garra A; Young DB; Wilkinson RJ
mBio; 2021 Dec; 12(6):e0176621. PubMed ID: 34872348
[TBL] [Abstract][Full Text] [Related]
5. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
Namasivayam S; Sher A; Glickman MS; Wipperman MF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
de Wet TJ; Warner DF; Mizrahi V
Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. Sputum is a surrogate for bronchoalveolar lavage for monitoring Mycobacterium tuberculosis transcriptional profiles in TB patients.
Garcia BJ; Loxton AG; Dolganov GM; Van TT; Davis JL; de Jong BC; Voskuil MI; Leach SM; Schoolnik GK; Walzl G; Strong M; Walter ND
Tuberculosis (Edinb); 2016 Sep; 100():89-94. PubMed ID: 27553415
[TBL] [Abstract][Full Text] [Related]
11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
[TBL] [Abstract][Full Text] [Related]
13. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
Shah T; Shah Z; Baloch Z; Cui X
Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
[TBL] [Abstract][Full Text] [Related]
14. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis: steady dynamics between past and present to imagine the future].
Cabello C F
Rev Med Chil; 2011 Jul; 139(7):829-32. PubMed ID: 22051818
[TBL] [Abstract][Full Text] [Related]
16. The Capacity of
Kurthkoti K; Amin H; Marakalala MJ; Ghanny S; Subbian S; Sakatos A; Livny J; Fortune SM; Berney M; Rodriguez GM
mBio; 2017 Aug; 8(4):. PubMed ID: 28811344
[TBL] [Abstract][Full Text] [Related]
17. The secret trumps, impelling the pathogenicity of tubercle bacilli.
Cardona PJ; Ivanyi J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
19.
Nunes JES; Duque MA; de Freitas TF; Galina L; Timmers LFSM; Bizarro CV; Machado P; Basso LA; Ducati RG
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168746
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
